(2004) Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY336 but resistant to ghrelin
Abdulla, R
SB reports employment with Boston Scientific
Emerging PSYs such as DMT, a serotonin-acting compound, and ibogaine, an atypical multi-receptor modulator, show distinct pharmacodynamic profiles
Much like checking only the speed of a car without looking at fuel or engine health, relying on Read More Stopping GLP-1 Therapy: New Data Highlight the Challenge of Weight Regain Mar 27, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity 1,534 views Have you ever wondered why weight seems to come back so quickly after stopping a medication that once worked so well
Real-world experience of adjunct weekly semaglutide in type 1 diabetes